If ACR were a miner with that news the price would rocket, or if a Biotech in the US same thing,but unfortunately this is an Aust listed Biotech. I think too many in the market just see them as a Roulette wheel.
Plenty of good news still to come with ACR. Don't doubt the value in the Animal Product. The delivery platform is what the company is about. It's got to be easier spraying something on kitty or rover than trying to force pills or squirt something down its throat.
Provided the uptake with humans in the next 12 months of the delivery system is good/hoping great then things will change. I think Lilly is waiting to see how that goes. As mentioned with the backing of Lilly its going to be pushed.
Add to My Watchlist
What is My Watchlist?
